Covance Inc.

PRINCETON, N.J., May 13, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013 at 11:00 a.m. (ET). Investors may access a live webcast of the presentation ... read more

PRINCETON, N.J., May 6, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the R. W. Baird 2013 Growth Stock Conference on Wednesday, May 8, 2013 at 3:45 p.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. ... read more

PRINCETON, N.J., April 3, 2013 /PRNewswire/ -- In conjunction with its first quarter 2013 earnings release (expected to be issued after market close on May 1, 2013), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be ... read more

PRINCETON, N.J., April 16, 2013 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced completion of the expansion of its central laboratory facility in Singapore to enhance the company's current service offerings and position it to meet current and future growth ... read more

PRINCETON, N.J., April 3, 2013 /PRNewswire/ -- In conjunction with its first quarter 2013 earnings release (expected to be issued after market close on May 1, 2013), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be ... read more

PRINCETON, N.J., Feb. 22, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Citi 2013 Global Healthcare Conference on Tuesday, February 26, 2013 at 2:15 p.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In ... read more

PRINCETON, N.J., Feb. 11, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Leerink Swann Global Healthcare Conference on Wednesday, February 13, 2013 at 8:30 a.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In ... read more

PRINCETON, N.J., Jan. 3, 2013 /PRNewswire/ -- In conjunction with its fourth quarter 2012 earnings release (expected to be issued after market close on January 24, 2013), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be ... read more

PRINCETON, N.J., Jan. 24, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today reported results for its fourth quarter and year ended December 31, 2012. On a GAAP basis, net revenue was $562 million in the fourth quarter and $2,181 million for the full year. ... read more

PRINCETON, N.J., Jan. 7, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the 31(st) Annual J. P. Morgan Healthcare Conference on Wednesday, January 9, 2013 at 12:00 p.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. ... read more

PRINCETON, N.J., Jan. 3, 2013 /PRNewswire/ -- In conjunction with its fourth quarter 2012 earnings release (expected to be issued after market close on January 24, 2013), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be ... read more

PRINCETON, N.J., Dec. 3, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that its early development facility located in Shanghai, China, has received a Good Laboratory Practice (GLP) Certificate from the State Food and Drug Administration (SFDA) of the People's Republic of China. The Covance ... read more

PRINCETON, N.J., Dec. 3, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced that the CEO Roundtable on Cancer accredited the company with the CEO Cancer Gold Standard(TM), recognizing the organization's extraordinary commitment to the health of its employees ... read more